MEDISCA issues U.S. Patent 10,420,705 for planetary mixers adapter
Category: #health  By Pankaj Singh  Date: 2020-02-06
  • share
  • Twitter
  • Facebook
  • LinkedIn

MEDISCA issues U.S. Patent 10,420,705 for planetary mixers adapter

MEDISCA Inc., a global leader in the pharmaceutical compounding industry, has recently announced the issuance of U.S. Patent 10,420,705 for an adapter used in planetary mixers. This adapter caters to customers who seek homogeneity and faster mixing times, the same as that being offered by rotation-revolution mixers. In the pharmaceutical setting, this final mixed product could be placed in the same dispenser used by pharmacists in their regular compounding activities.

The company is making consistent strides in the field of pharmaceutical compounding and seeking innovations, which is reflected by the company’s recent addition of Patent 10,420,705 to its existing global patent portfolio.

In the recent past, the company also filed patents on the uses and functionalities of the MAZ™, namely United States Patents 10,420,705 and 10,231,903. MAZ™ is a well-known brand of a high-performing planetary mixer, which has been adopted in large number of compounding pharmaceutical settings, worldwide. The brand is currently made available exclusively by MEDISCA.

According to MEDISCA’s Senior Director, Panagiota Danopoulos, the company swiftly identifies customers’ issues while dealing with specific business process, and promptly delivers innovative solutions to them for easy workflow. The company is dedicated to offering the highest level of quality ingredients used for medications as well as ensuring the safety and effectiveness of the compounding process to customers it serves.

MEDISCA possesses several intellectual property rights and these portfolios have been expanding globally across Canada, the United States, and other key commercial markets. The company intends to continue placing extra focus on providing top class pharmaceutical compounding ingredients while delivering innovative products and services, in order to avoid any adverse claims.

Additionally, the company is planning to make significant investments in research and development activities, marketing products, issuing patents, as well as increasing trademark portfolios to promote its high-quality products and services on a global scale.

Source credit:

https://apnews.com/Business%20Wire/f0247025465a4d009671a6e8d9c78d4c



About Author

Pankaj Singh

Email: [email protected]   

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More News By Pankaj Singh

Gilead’s Remdesivir improves clinical outcomes in COVID-19 patients
Gilead’s Remdesivir improves clinical outcomes in COVID-19 patients
By Pankaj Singh

The novel coronavirus outbreak, which led to the on-going COVID-19 pandemic, has affected over five million people and taken the lives of over 300 thousand worldwide. But unfortunately, researchers have not been able t...

WHO halts Hydroxychloroquine clinical trial over safety concerns
WHO halts Hydroxychloroquine clinical trial over safety concerns
By Pankaj Singh

The malaria drug Hydroxychloroquine has been in the headlines for the past few months. The drug was hailed as the game-changer in the treatment of COVID-19 by the Trump administration. However, the WHO (World Health Or...

BPCL launches WhatsApp initiative to facilitate domestic gas booking
BPCL launches WhatsApp initiative to facilitate domestic gas booking
By Pankaj Singh

  • BPCL has launched a domestic gas booking facility through WhatsApp
     
  • “Bharat Gas” cylinders can be booked through a Smartli...